Skip to main content

Table 1 Characteristics of included studies

From: Plasma leakage in dengue: a systematic review of prospective observational studies

Study

Recruitment period

Dengue diagnosis*

Community (C) or Hospital (H) based

Participants

Country

WHO classification system used

Reports DHF/PL/Both

Adil 2020 [8]

Sep 2019–Jan 2020

A, S

H

Adults

Pakistan

1997

Both

Alexander 2011 [9]

Aug 2006–May 2007

P, S

H**

Both

Thailand, Malaysia, Philippines, Nicaragua, Vietnam, Venezuela, Brazil

Both#

DHF

Avirutnan 2006 [11]

Nov 2001–Dec 2003

A, P

H

Children

Thailand

1997

DHF

Basuki 2010 [12]

Oct 2008–Apr 2009

P, S

H

Children

Indonesia

Both

Both

Biswas 2015 [13]

Aug 2005–Jan 2013

S, P, O

H**

Children

Nicaragua

Both

DHF

Bodinayaka 2018 [14]

Not mentioned

S, P, O

H

Both

Sri Lanka

2009

PL

Capeding 2015 [15]

Nov 2009–Nov 2010

S, P

H

Children

Philippines

1997

DHF

Chattergee 2017 [16]

Aug 2013–Jan 2014

A, S

H

Both

India

Both

DHF

Cordeiro 2007 [17]

Feb 2004–2006

A, S, P, O

H

Both

Brazil

1997

DHF

Fariz-Safhan 2014 [18]

Jul 2005–Jun 2006

S

H

Unclear

Malaysia

1997, 2002

Both

Guilarde 2008 [19]

Jan 2005–Jul 2005

S, P, O

H

Adults

Brazil

1997

DHF

Herath 2019 [20]

Aug 2016–Aug 2017

A

H

Adults

Sri Lanka

Not used

PL

Jagadishkumar 2012 [21]

Nov 2008–Jul 2010

S

H

Children

India

1997

DHF

Jain 2017 [22]

Aug 2015–Nov 2015

A, S

H

Adults

India

1997

DHF

Kirawittaya 2015 [23]

2010–2012

S, P

H

Children

Thailand

Both

DHF

Kittigul 2007 [24]

Sep 2003–Aug 2004

S

H

Both

Thailand

1997

DHF

Kularatnam 2019 [25]

July 2013–April 2014

S

H

Children

Sri Lanka

1997

DHF

Kulasinghe 2016 [26]

Apr 2013–Oct 2013

S

H

Children

Sri Lanka

 

PL***

Laul 2016 [27]

Jun 2015–Aug 2015

A, S

H

Adults

India

1997

DHF

Malavige 2006 [29]

Apr 2004–Jul 2004

S

H

Children

Sri Lanka

1997

DHF

Malavige 2006 [30]

Apr 2004–Jul 2004

S, P

H

Adults

Sri Lanka

1997

DHF

Manamperi 2019 [31]

Jan 2017–Dec 2017

A, S

H

Children

Sri Lanka

1997

DHF

Pham 2009 [32]

Jul 2007–Oct 2007

P, O

H

Adults

Vietnam

Not used

PL

Phuong 2004 [33]

Jun 1996–Jun 1998

S, O

H

Children

Vietnam

1997

DHF

Poeranto 2016 [34]##

1995–1999

S, P, O

H

Children

Indonesia

1997

DHF

Potts 2010 [47]

1994–2007

S, P, O

H

Children

Thailand

1997

DHF

Prasad 2020 [35]

Jul 2014–Jul 2015

S

H

Children

India

2009

PL

Premaratne 2013 [36]

Jul 2011–Dec 2011

S

H

Adults

Sri Lanka

1997

PL

Raman 2013 [37]

Feb 2011–Nov 2012

S

H

Adults

Bangladesh

1997, 2011

DHF

Seet 2006 [39]

Oct 2005–Nov 2005

S

H

Adults

Singapore

1997

DHF

Senaratne 2016 [40]

Jul 2011–Feb 2012

S, P

H

Adults

Sri Lanka

1997, 2011

DHF

Sigera 2021 [49]

Oct 2017–Feb 2020

A, P

H

Adults

Sri Lanka

2009

PL

Suwarto 2016 [41]

Mar 2010–Aug 2015

A, P

H

Adults

Indonesia

Not used

PL

Tang 2008 [48]

Aug 2006–Oct 2006

S

H

Both

China

1997

DHF

Taylor 2015 [42]

Sep 2008–Nov 2008

A, S, P

H

Adults

Vietnam

2009

PL

Thomas 2012 [43]

Jan 2005–Dec 2010

S, P

H

Adults

Martinique (France)

Both

Both

Trung 2012[50]

Sep 2006 – Sep 2008

A, S, P

H

Both

Vietnam

1997

PL###

Vasanwala 2014 [44]

Jan 2012–Aug 2012

A, P

H

Adults

Singapore

1997

DHF

Yacoub 2017 [45]

Jun 2013–Oct 2015

A, S, P

H

Both

Vietnam

2009

PL

Yung 2015 [46]

Apr 2005–Dec 2011

A, S, P

H

Adults

Singapore

Both

DHF

Anderson 2011 [10]

Jan 1998–2002

P, S

C

Children

Thailand

1997

DHF

L’Azou 2016 [28]

Jun 2011–Apr 2014

A, P

C

Children

Indonesia, Malaysia, Philippines, Thailand, Vietnam, Brazil, Honduras, Mexico, Puerto Rico, Colombia

1997

DHF

Sabchareon 2012 [38]

Feb 2006–2009

S, P, O

C

Children

Thailand

1997

DHF

  1. *NS1 antigen test (A), RT-PCR (P), Serology—IgM or IgG and IgM combination or paired IgG analysis only (S), Other—viral isolation (O), **Mentions that some patients were managed as outpatients and proportion of in-patient DHF patients were extracted or calculated, for other studies all patients were assumed have been managed as in-patients, ***diagnosis of “DHF” was synonymous with plasma leakage, #Primary study for 2009 WHO dengue classification, ##Reclassification of a previous cohort, ###This study provides the number of patients with a haematocrit rise > 20%, rather than plasma leakage